BioCentury
ARTICLE | Emerging Company Profile

Bio-Modeling: Negative selection

February 13, 2006 8:00 AM UTC

Bio-Modeling Systems S.A.S. says its in silico drug discovery system, Computer Assisted Deductive Integration (CADI), is working better than previous bioinformatics discovery systems because it is based on the contrarian approach of disproving hypotheses rather than the more traditional method of supporting them, and because the company uses biologists to generate predictions. The company has published its first validated hypotheses and is looking to partner them with drug developers.

"A lot of the issues identified by pharma as being bottlenecks are related to the lack of predictive technologies," said Manuel Gea, co-founder, CEO and vice president of R&D information systems at Bio-Modeling (Paris, France). ...